1. Pfizer and Wyeth - $68B
2. Roche and Genentech - $46.8B
3. MercK and Schering-Plough - $41.1B
4. Novartis and Alcon - $28.1B
5. Sanofi-Aventis and Merck - $4B
6. GlaxoSmithKline and Stiefel Labs - $3.6B
7. Warner Chilcott and P&G - $3.1B
8. BMS and Medarex - $2.4B
9. GlaxoSmithKline and Brazil - $2.2B
10. Roche and PTC Therapeutics - $2B
Read more: http://www.fiercebiotech.com/special-reports/top-10-biopharma-deals-2009#ixzz0eKQg0a6I
No comments:
Post a Comment